Eikon Therapeutics, Inc. (EIKN)

Eikon Therapeutics Statistics

Total Valuation

EIKN has a market cap or net worth of $511.07 million. The enterprise value is $432.41 million.

Market Cap	511.07M
Enterprise Value	432.41M

Important Dates

The last earnings date was Monday, March 30, 2026, before market open.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

EIKN has 54.14 million shares outstanding.

Current Share Class	54.14M
Shares Outstanding	54.14M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+13.21%
Owned by Insiders (%)	5.89%
Owned by Institutions (%)	2.90%
Float	27.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.81
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.34, with a Debt / Equity ratio of 0.91.

Current Ratio	6.34
Quick Ratio	6.11
Debt / Equity	0.91
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-375.66

Financial Efficiency

Return on equity (ROE) is -125.02% and return on invested capital (ROIC) is -40.17%.

Return on Equity (ROE)	-125.02%
Return on Assets (ROA)	-36.19%
Return on Invested Capital (ROIC)	-40.17%
Return on Capital Employed (ROCE)	-58.26%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$111.21M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	33.23
Average Volume (20 Days)	426,451

Short Selling Information

The latest short interest is 2.17 million, so 4.00% of the outstanding shares have been sold short.

Short Interest	2.17M
Short Previous Month	1.59M
Short % of Shares Out	4.00%
Short % of Float	7.87%
Short Ratio (days to cover)	6.01

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-314.43M
Pretax Income	-324.25M
Net Income	-333.64M
EBITDA	-295.55M
EBIT	-314.43M
Earnings Per Share (EPS)	-$115.29

Balance Sheet

The company has $335.98 million in cash and $257.32 million in debt, with a net cash position of $78.66 million or $1.45 per share.

Cash & Cash Equivalents	335.98M
Total Debt	257.32M
Net Cash	78.66M
Net Cash Per Share	$1.45
Equity (Book Value)	282.44M
Book Value Per Share	-286.47
Working Capital	293.91M

Cash Flow

In the last 12 months, operating cash flow was -$188.52 million and capital expenditures -$46.74 million, giving a free cash flow of -$235.26 million.

Operating Cash Flow	-188.52M
Capital Expenditures	-46.74M
Depreciation & Amortization	18.87M
Net Borrowing	n/a
Free Cash Flow	-235.26M
FCF Per Share	-$4.35

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

EIKN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-65.28%
FCF Yield	-46.03%

Analyst Forecast

The average price target for EIKN is $25.60, which is 171.19% higher than the current price. The consensus rating is "Buy".

Price Target	$25.60
Price Target Difference	171.19%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1